Pfizer CEO Bourla says company ready to execute in a 'pivotal' 2023: report

After Pfizer launched to pandemic superstar status with its BioNTech-partnered COVID-19 vaccine, Comirnaty, the company has something to prove with its next few launches. And next year is setting up to be a pivotal year for the drugmaker, one that could feature up to 10 new launches, CEO Albert Bourla, Ph.D., said in an interview at Yahoo Finance’s All Markets Summit.